Usefulness of low-dose Methotrexate monotherapy for treating sarcoidosis

Internal Medicine

Volumn 52, Issue 24, 2013, Pages 2727-2732

  Isshiki, Takuma ^a   Yamaguchi, Tetsuo ^a   Yamada, Yoshihito ^a   Maemura, Keita ^a   Makita, Kosuke ^a   Takeshima, Hideyuki ^a   Hirasawa, Yasutaka ^a   Yamaguchi, Yoko ^a   Hosoki, Keisuke ^a   Suzuki, Mika ^a   Kono, Chiyoko ^a   Terada, Jiro ^b   Tatsumi, Koichiro ^b  

^a Japan Railway Tokyo General Hospital   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Alternative therapy; Corticosteroids; Cytotoxic agent; Methotrexate; Sarcoidosis

Indexed keywords

CORTICOSTEROID; METHOTREXATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIGESTIVE SYSTEM DISEASE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HAIR LOSS; HUMAN; LEUKOPENIA; LIVER TOXICITY; LOW DRUG DOSE; LUNG LESION; MALE; SARCOIDOSIS;

ADULT; AGED; DERMATOLOGIC AGENTS; FEMALE; HUMANS; JAPAN; MALE; METHOTREXATE; MIDDLE AGED; RETROSPECTIVE STUDIES; SARCOIDOSIS; TREATMENT OUTCOME;

EID: 84890532529     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.52.0976     Document Type: Article

References (33)

1. ATS/ERS/WASOG Statement on sarcoidosis. Am J Respir Crit Care Med 160: 736-755, 1999.
2. James DG, Carstairs LS, Trowell J, et al. Treatment of sarcoidosis. Lancet 2: 526-528, 1967.
3. Sharma OP. Pulmonoary sarcoidosis and corticosteroids. Am Rev Respir Dis 147: 1598-1600, 1993.
4. Paramothayan S, Lasserson T. Treatment for pulmonary sacroidosis. Respir Med 102: 1-9, 2008.
5. Williams HJ, Willkens RF, Samuelson CO, et al. Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum 28: 721-730, 1985.
6. Kremer JM, Lee JK. A long-term prospective study of the use of methotrexate in rheumatoid arthritis. Arthritis Rheum 31: 577-584, 1988.
7. Smolen JS, Landewe R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 69: 964-975, 2009.
8. Chan ES, Cronstein BN. Molecular action of methotrexate in inflammatory diseases. Arthritis Res 4: 266-273, 2002.
9. Baughman RP, Lower EE. The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis. Am Rev Respir Dis 142: 1268-1271, 1990.
10. Baughman RP, Lower EE. A clinical approach to the use of methotrexate for sarcoidosis. Thorax 54: 742-746, 1999.
11. Lower EE, Baughman RP. Prolonged use of methotrexate for sarcoidosis. Arch Intern Med 155: 846-851, 1995.
12. Baughman RP, Winget DB, Lower EE. Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis 26: 77-82, 2006.
13. Kaye O, Palazzo E, Grossin M, et al. Low-dose methotrexate: An effective corticosteroid-sparing agent in the musculoskeletal manifestations of sarcoidosis. Br J Rheumatol 34: 642-644, 1995.
14. Lower EE, Broderick JP, Brott TG, et al. Diagnosis and management of neurological sarcoidosis. Arch Intern Med 157: 1864-1868, 1997.
15. Diagnostic Standard and Guideline for Sarcoidosis-2006. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders 27: 89-102, 2007 (in Japanese).
16. Gibson GJ, Prescott RJ, Muers MF, et al. British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment. Thorax 51: 238-247, 1996.
17. Lacher MJ. Spontaneous remission response to methotrexate in sarcoidosis. Ann Intern Med 155: 1247-1248, 1968.
18. Suda T, Sato A, Toyoshima M, et al. Weekly low-dose methotrexate therapy for sarcoidosis. Intern Med 33: 437-440, 1994.
19. Tanaka K, Yamaguchi T, Zaima M, et al. Two cases of sarcoidosis successfully treated by methotrexate alone. The Japanese Journalof Sarcoidosis and Other Granulomatous Disorders 30: 9-13, 2010 (in Japanese).
20. Lynch JP, McCune WJ. Immunosuppresive and cytotoxic pharmacotheraphy for pulmonary disorders. Am J Respir Crit Care Med 155: 395-420, 1997.
21. Lynch JP, Kazerooni EA, Gay SE. Pulmonary sarcoidosis. Clinic Chest Med 18: 755-785, 1993.
22. Tolman KG, Clegg DO, Lee RG, et al. Methotrexate and the liver. J Rheumatol Suppl 12: 29-34, 1985.
23. Baughman RP. Methotrexate for sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 15: 147-149, 1998.
24. Miyara H, Morishita M, Magaki K, et al. Sekkaikawo tomonaukaijoueiwoteishi methotorexate noshouryotouyode kaizenno mirareta sarcoidosis noichirei. Japanese Journal of Sarcoidosis and other Other Granulomatous Disorders 15: 108-109, 1996 (in Japanese).
25. Tsukamoto K, Hiraoka H, Maruyama T, et al. Combined treatment with corticosteroid and low-dose methotrexate for cardiac sarcoidosis: A case report. Shinzou 29: 213-218, 1997 (in Japanese).
26. Kato H, Morishita M, Oki Y, et al. Successful methotrexate treatment in a patient with steroid resistant myocardial sarcoidosis. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders 19: 45-49, 1999 (in Japanese, abstract in English).
27. Azuma H, Ohara K, Yamaguchi K, et al. Ocular sarcoidosis-a case report of a patient with typical granulomatous iris lesion. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders 21: 47-51, 2001 (in Japanese, abstract in English).
28. Kato Y, Morimoto S, Uemura A, et al. Four cases of cardiac sarcoidosis treated with methotrexate. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders 23: 83-86, 2003 (in Japanese, abstract in English).
29. Ikewaki J, Nakano S, Nakatsuka K. A Case of sarcoid-associated optic neuropathy successfully treated with Methotrexate. NeuroOphthalmology Japan 21: 425-432, 2004 (in Japanese, abstract in English).
30. Ono S, Suzuki Y, Ishikawa H, et al. Combination therapy of lowdose methotrexate and corticosteroid in the treatment of central nervous system sarcoidosis. Shinkeichiryo 23: 139-144, 2006 (in Japanese, abstract in English).
31. Shinohara A, Tanioka M, Tkahashi K, et al. A case of lichenoid sarcoidosis improved by oral methotrexate. Rinshohihuka 63: 557-560, 2009 (in Japanese).
32. Ohmichi M. Steroid genryoji no zouakuji ni methotrexate ga yukoudatta hai sarcoidosis no ichirei. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders 29: 47-53, 2009 (in Japanese).
33. Adachi A, Nishitani N. Ulcerative sarcoidosis of the face improved by oral methotrexate. Hihukanorinsho 52: 1085-1089, 2010 (in Japanese).